17th October 2008

Richmond Pharmacology, the 1st Early Phase CRO to receive MHRA Standard and Supplementary Accreditation for 2 hospital based Clinical Trial Centers.

Richmond Pharmacology. (RPL) have proudly received MHRA Standard and Supplementary Accreditation, a clear sign of our continued commitment to providing the highest level of subject safety on all studies conducted within our two hospital based Early Phase trial centres. RPL is unique in being the only Early Phase CRO in the UK to have two trial centres based in two acute NHS teaching hospitals.

The supplementary accreditation confirms that RPL have attained the highest level of accreditation available in Europe. This permits RPL to perform the full range of Early Phase studies, including trials requiring a review of risk factors by the Expert Advisory Group (EAG).

The combination of this accreditation award, our experience from conducting in excess of 400 Early Phase studies and our world-leading scientific advisory board means our sponsors can rely on RPL to continue to lead the industry in the conduct of FTIM studies, as well as other specialty areas such as TQT Studies, Japanese bridging studies, gastrointestinal studies and patient studies.

For more information on the MHRA Phase I accreditation scheme visit the MHRA website.

For further information on RPL's Early Phase facilities and expertise,
please review our brochures.

11th June 2008

Richmond Pharmacology's Volunteer Recruitment Databaseis a bespoke system designed to allow the entire journey of a volunteer to be tracked‚ from initial registration through study conduct to final follow up. This ensures that all information on our volunteers is available at the click of a button allowing us to provide you our sponsors with accurate up to date metrics on those volunteers you need for enrolment in your studies.

A few facts:

79 000 registered subjects to date (June 2008) includes but is certainly not limited to populations such as healthy young male and female elderly slim obese plus various patient and specialist populations, e.g. Japanese volunteers asthmatics diabetics MS patients those on warfarin and renally impaired subjects,

On average between 1200 to 1500 subjects are registered per monthOngoing recruitment marketing campaigns direct volunteers to one of our three dedicated recruitment websites www.trials4us.co.uk www.trials4japanese.co.uk www.trials4patients.co.uk.

The database has an activity level of approx 75%. I.e.75% of the population are currently actively looking for trials or are involved in trials Finally we have a significant number of volunteers who are repeat trialists due to the broad portfolio of trials which we recruit for and because the treatment they receive within our unit is of a very high clinical standard.

Here are a few examples of comments received from our volunteers:

The clinical staff and doctors are first class in every way. The trial was a real success‚ The staff are lovely and helpful if you have any problems they help you out. I would recommend trials4us to my friends because it’s a good paid holiday; also I give the facilities a 10 out of 10‚..

The facilities are excellent; I give them 10 out of 10! I would definitely recommend trials4us to my friends; it’s a fun safe way to earn a very good amount of money‚ During the day on the ward I like to use the computer read lots of magazines and talk to friends who are also volunteering in the trial.

I think that the staff at Trials4us are wonderful‚ During the day I spend my time reading books surfing the internet watching movies playing card and board games.

The staff are excellent, I really love the staff. The facilities are excellent I would give them 9 out of 10.

For more information on our Volunteer Database or to discuss a forthcoming study please contact Charlotte Gowling.